Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

U Of Pittsburgh Adds Vaccine Partners

by Rick Mullin
March 22, 2010 | A version of this story appeared in Volume 88, Issue 12

Battelle, IBM, and Merck & Co. have joined the University of Pittsburgh Medical Center and GE Healthcare in a vaccine facility initiative at UPMC. Battelle will provide preclinical R&D services, IBM will provide data analysis technology, and Merck will consult on drug development and bioprocessing. GE announced in October that it would provide design and development expertise, as well as equipment for the facility, which would be designed to produce multiple vaccines simultaneously and switch output from one vaccine to another in response to an emergency. The partnership, which is expected to create 1,000 jobs, plans to compete for government funding.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.